Castle Biosciences Inc (CSTL) - News Archive

: The evolving landscape of melanoma diagnosis and management continues to demand innovative tools for precise risk stratification, particularly for early-stage patients. Recent presentations at the AACR Annual Meeting...

Castle Biosciences is poised to present compelling new data supporting the clinical utility of the DecisionDx-Melanoma test at the upcoming 11th World Congress of Melanoma and the 21st European Association of Dermato-On...

Castle Biosciences Inc, a prominent player in the biotechnology and medical research industry, has experienced a significant dip in its stock price, causing investors to question its current value. On July 5, 2024, the...